Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.5500
-0.0151 (-2.67%)
At close: Sep 26, 2025, 4:00 PM EDT
0.5600
+0.0100 (1.82%)
After-hours: Sep 26, 2025, 7:36 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $22.98 million as of September 26, 2025. Its market cap has decreased by -50.09% in one year.
Market Cap
22.98M
Enterprise Value
-22.71M
1-Year Change
-50.09%
Ranking
Category
Stock Price
$0.55
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $22.98M, a decrease of -94.33%. That is a compound annual growth rate of -49.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 22.98M | -42.30% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 665.99B |
| Johnson & Johnson | 425.53B |
| AbbVie | 388.63B |
| UnitedHealth Group | 318.63B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 233.03B |